SANN — Santhera Pharmaceuticals Holding AG Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Market Cap
CH₣108.75m
Enterprise Value
CH₣99.93m
Revenue
CH₣103.38m

Annual balance sheet for Santhera Pharmaceuticals Holding AG, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	31.4	12.4	21.2	1.35	30.4
Net Total Accounts Receivable
Net Total Receivables	8.9	4.49	1.94	1.09	2.15
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	49.3	17.7	24.6	3.06	34.7
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5.6	1.9	1.32	1.01	0.582
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	115	88.7	91.1	63.7	110
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	24	29.1	32.8	49.4	43.8
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	93.8	95	89.8	107	49.2
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	21.2	-6.35	1.33	-43.7	60.5
Total Liabilities & Shareholders' Equity	115	88.7	91.1	63.7	110
Total Common Shares Outstanding